NCT00000441已完成4 期
Carbamazepine and Lorazepam in Outpatient Detoxification
National Institute on Alcohol Abuse and Alcoholism (NIAAA)2 个研究点 分布在 1 个国家开始时间: 1999年11月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 试验地点
- 2
研究概览
简要总结
This project will provide relevant clinical information for primary care practitioners treating alcohol withdrawal syndrome in outpatient settings. This double-blind, placebo- controlled clinical trial will compare the effectiveness of lorazepam (Ativan) and carbamazepine (Tegretol) in alcoholics who meet the criteria for a diagnosis of uncomplicated alcohol withdrawal syndrome. Participants are randomized to five days of treatment with a 1-week posttreatment followup.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 21 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meets criteria for alcohol dependence and uncomplicated alcohol withdrawal syndrome.
- •Ability to provide informed consent, complete self-rating questionnaires, and respond to structured clinician-rated instruments.
- •Must live within 50 miles or one hour of the study site and have reliable transportation to the site.
- •Must have a significant other who will provide a collateral report, attend outpatient visits, and be available by telephone.
- •Subjects must be medically stable.
- •Must have a clinical withdrawal assessment prior to study.
排除标准
- •Meets criteria for any other substance dependence syndrome other than alcohol dependence or marijuana abuse.
- •Use of other illicit psychoactive substances (except marijuana) in the last 7 days.
- •Use of pharmaceutical agents within the last 14 days that are known to lower the seizure threshold, augment or decrease the alcohol withdrawal syndrome.
- •History of status epilepticus or two or more seizures occurring within 24- hour period during a previous alcohol withdrawal or other forms of epilepsy.
- •Current major depressive illness, dementia, suicidal or homicidal ideation, or past or present schizophrenia.
- •Acute medical instability as characterized by hepatic encephalopathy, past or present severe liver failure.
- •Diabetes requiring insulin, or severe renal disease.
- •Pregnant females.
- •High blood pressure.
- •Individuals with vomiting who cannot take oral medications at beginning of study or whose vomiting can be controlled only with antiemetic medication.
- •High white blood count, or liver function test that is 3 times higher than normal.
- •Known hypersensitivity or previous adverse reaction to carbamazepine, lorazepam, or other benzodiazepines.
- •Any relevant ECG abnormality which might require hospitalization or greatly interfere with safety during outpatient withdrawal.
- •History of severe gastrointestinal (GI) disease which might render absorption of the medication difficult or produce medical instability of the patient during detoxification which would include active peptic ulcer disease, ulcerative colitis, regional ileitis, or evidence by history or physical examination of GI bleeding.
- •Familial tremor or other neurological condition, determined by history, known to produce tremor.
- •Unable to provide a written informed consent.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Treatment of Alcohol Withdrawal in Hospital PatientsAlcohol Withdrawal SyndromeNCT00249366Virginia Commonwealth University183
进行中（未招募）
1 期
Alcohol detoxification in primary care treatment (ADEPT) - a feasibility study of conducting a randomised trial in primary care comparing two pharmacological regimens. - Alcohol detoxification in primary care treatment (ADEPT)Alcohol dependencethose requiring medication for alcohol detoxificationMedDRA version: 9.1 Level: LLT Classification code 10050629 Term: Alcohol detoxificationEUCTR2008-004820-22-GBniversity of Bristol60
已完成
3 期
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in JapanStatus EpilepticusNCT02239380Pfizer26
Unknown
4 期
Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use DisorderPsychosisSubstance Use DisordersNCT03857581Augusta University100
已完成
4 期
Long Term Treatment of Panic Disorder With Clonazepam or ParoxetineAgoraphobiaPanic DisorderNCT02852577Universidade Federal do Rio de Janeiro120